<DOC>
	<DOCNO>NCT00210990</DOCNO>
	<brief_summary>The purpose study assess microbiological cure rate doripenem treatment patient complicate urinary tract infection pyelonephritis . The study also characterize safety tolerability treatment doripenem patient complicate urinary tract infection pyelonephritis .</brief_summary>
	<brief_title>Doripenem Treatment Complicated Lower Urinary Tract Infection Pyelonephritis</brief_title>
	<detailed_description>Doripenem antibiotic medication yet approve US FDA . This phase 3 , multi-center , prospective , open-label , single-arm study doripenem treatment complicate low urinary tract infection pyelonephritis adult . Patients hospitalize , subsequently , patient may treat outpatient home-based therapy discretion investigator . Conventional laboratory data collect patient specify time throughout study . The primary endpoint microbiological response measure test cure visit . The patient receive doripenem duration therapy 10 day .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Pyelonephritis</mesh_term>
	<criteria>Diagnosis complicate low urinary tract infection pyelonephritis Women pregnant , nurse childbearing potential use medically accept , effective method birth control History moderate severe hypersensitivity reaction antibiotic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Complicated Urinary Tract Infections</keyword>
	<keyword>Pyelonephritis</keyword>
</DOC>